UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11906) 11906
Book Chapter (138) 138
Dissertation (25) 25
Magazine Article (22) 22
Publication (9) 9
Reference (6) 6
Web Resource (6) 6
Conference Proceeding (5) 5
Government Document (3) 3
Paper (2) 2
Book / eBook (1) 1
Book Review (1) 1
Journal / eJournal (1) 1
Poster (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9766) 9766
imatinib mesylate (9258) 9258
science & technology (8684) 8684
life sciences & biomedicine (8357) 8357
benzamides (6871) 6871
pyrimidines - therapeutic use (4943) 4943
piperazines - therapeutic use (4755) 4755
male (4141) 4141
oncology (4044) 4044
antineoplastic agents - therapeutic use (3943) 3943
female (3740) 3740
imatinib (3664) 3664
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (3553) 3553
middle aged (3279) 3279
adult (2817) 2817
hematology (2759) 2759
pyrimidines - pharmacology (2466) 2466
aged (2398) 2398
piperazines - pharmacology (2349) 2349
chronic myeloid leukemia (2091) 2091
treatment outcome (1969) 1969
protein kinase inhibitors - therapeutic use (1799) 1799
animals (1777) 1777
antineoplastic agents - pharmacology (1470) 1470
pyrimidines - administration & dosage (1453) 1453
protein-tyrosine kinases - antagonists & inhibitors (1445) 1445
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1433) 1433
leukemia (1375) 1375
piperazines - administration & dosage (1362) 1362
gastrointestinal stromal tumors - drug therapy (1330) 1330
cancer (1266) 1266
pyrimidines - adverse effects (1228) 1228
mutation (1201) 1201
hemic and lymphatic diseases (1148) 1148
piperazines - adverse effects (1142) 1142
drug resistance, neoplasm (1117) 1117
leukemia, myelogenous, chronic, bcr-abl positive - pathology (1110) 1110
fusion proteins, bcr-abl - genetics (1098) 1098
protein kinase inhibitors - pharmacology (1031) 1031
mice (1021) 1021
abridged index medicus (1020) 1020
antineoplastic agents (1006) 1006
antineoplastic agents - adverse effects (961) 961
care and treatment (952) 952
cell line, tumor (946) 946
antineoplastic agents - administration & dosage (901) 901
prognosis (894) 894
tyrosine (885) 885
adolescent (882) 882
antimitotic agents (877) 877
aged, 80 and over (874) 874
pharmacology & pharmacy (847) 847
imatinib mesylate - therapeutic use (824) 824
research (822) 822
dasatinib (792) 792
young adult (777) 777
benzamides - therapeutic use (772) 772
gastrointestinal stromal tumors - pathology (757) 757
tumors (741) 741
medicine & public health (740) 740
apoptosis - drug effects (737) 737
analysis (733) 733
neoplasms (714) 714
drug therapy (704) 704
proto-oncogene proteins c-kit - genetics (694) 694
kinases (680) 680
fusion proteins, bcr-abl - metabolism (656) 656
apoptosis (641) 641
cell biology (628) 628
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (603) 603
hematology, oncology and palliative medicine (585) 585
gastrointestinal stromal tumor (581) 581
drug resistance, neoplasm - genetics (578) 578
retrospective studies (571) 571
remission induction (567) 567
dose-response relationship, drug (566) 566
time factors (562) 562
biochemistry & molecular biology (561) 561
fusion proteins, bcr-abl - antagonists & inhibitors (558) 558
follow-up studies (551) 551
cell proliferation - drug effects (539) 539
genetic aspects (535) 535
k562 cells (535) 535
cml (533) 533
disease-free survival (526) 526
gastrointestinal stromal tumors - surgery (523) 523
surgery (521) 521
antineoplastic combined chemotherapy protocols - therapeutic use (506) 506
philadelphia chromosome (502) 502
health aspects (495) 495
imatinib mesylate - pharmacology (488) 488
signal transduction (488) 488
gist (485) 485
bcr-abl (479) 479
protein kinase inhibitors - administration & dosage (471) 471
gastrointestinal stromal tumors - genetics (459) 459
general & internal medicine (457) 457
stem cells (457) 457
chemotherapy (449) 449
phosphorylation (448) 448
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11242) 11242
Japanese (387) 387
Chinese (313) 313
French (161) 161
German (121) 121
Spanish (72) 72
Portuguese (47) 47
Korean (36) 36
Italian (33) 33
Russian (33) 33
Polish (22) 22
Hungarian (20) 20
Czech (14) 14
Danish (10) 10
Dutch (9) 9
Turkish (8) 8
Croatian (7) 7
Swedish (5) 5
Finnish (3) 3
Hebrew (3) 3
Romanian (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Indonesian (2) 2
Norwegian (2) 2
Slovak (2) 2
Lithuanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical cancer research, ISSN 1557-3265, 01/2008, Volume 14, Issue 2, pp. 352 - 359
Journal Article
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 03/2013, Volume 127, Issue 10, pp. 1128 - 1138
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 07/2011, Volume 29, Issue 21, pp. 2904 - 2909
Journal Article
Cancer biology & therapy, ISSN 1555-8576, 10/2014, Volume 4, Issue 7, pp. 747 - 752
Imatinib mesylate is a selective tyrosine kinase inhibitor that is successfully used in the treatment of Philadelphia-positive chronic and acute leukaemia's, and gastrointestinal stromal tumours... 
Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Gastrointestinal absorption | Oral bioavailability | Caco-2 cells | Tyrosine kinase inhibitor | ABC transporters | Pharmacokinetic resistance | Gleevec | Drug resistance | Life Sciences & Biomedicine | Oncology | Science & Technology | Neoplasms - metabolism | Piperazines - administration & dosage | Receptors, Steroid - metabolism | Gene Expression - drug effects | Drug Resistance, Multiple | Humans | Transcriptional Activation | Cercopithecus aethiops | Drug Resistance, Neoplasm | Antineoplastic Agents - administration & dosage | Multidrug Resistance-Associated Proteins - biosynthesis | RNA, Messenger - metabolism | ATP-Binding Cassette Transporters - genetics | Biological Transport | Neoplasms - genetics | Multidrug Resistance-Associated Proteins - genetics | Tumor Cells, Cultured | Neoplasm Proteins - genetics | ATP Binding Cassette Transporter, Subfamily G, Member 2 | Administration, Oral | Neoplasm Proteins - biosynthesis | Pyrimidines - administration & dosage | RNA, Messenger - genetics | Receptors, Cytoplasmic and Nuclear - genetics | Transcription Factors - genetics | Reverse Transcriptase Polymerase Chain Reaction | Imatinib Mesylate | ATP-Binding Cassette Transporters - biosynthesis | Transcription Factors - metabolism | Animals | Receptors, Steroid - genetics | Membrane Transport Proteins | Benzamides | Pregnane X Receptor | COS Cells | Protein-Tyrosine Kinases - antagonists & inhibitors | Receptors, Cytoplasmic and Nuclear - metabolism | Index Medicus
Journal Article
Journal Article
Journal Article